Efficacy of prophylactic droperidol, ondansetron or both in the prevention of postoperative nausea and vomiting in major gynaecological surgery. A prospective, randomized, double-blind clinical trial

• Published in: European journal of anaesthesiology Vol. 17; no. 10; p. 611
• Main Authors: Peixoto, A J, Peixoto Filho, A J, Leães, L F, Celich, M F, Barros, M A
• Format: Journal Article
• Language: English
• Published: England 01.10.2000
• Subjects: Adolescent; Adult; Aged; Aged, 80 and over; Antiemetics - administration & dosage; Antiemetics - therapeutic use; Double-Blind Method; Droperidol - administration & dosage; Droperidol - therapeutic use; Drug Therapy, Combination; Female; Gynecologic Surgical Procedures; Humans; Middle Aged; Ondansetron - administration & dosage; Ondansetron - therapeutic use; Postoperative Nausea and Vomiting - prevention & control; Prospective Studies
• ISSN: 0265-0215
• DOI: 10.1046/j.1365-2346.2000.00726.x

We conducted a prospective, randomized, double-blind clinical trial comparing droperidol 1.25 mg intravenously (i.v.) (group 1, n = 30), ondansetron 4 mg i.v. (group 2, n = 30), or both (group 3, n = 30) in the prevention of postoperative nausea and vomiting (PONV) in the first 24 h following major gynaecological procedures under combined general and epidural anaesthesia. PONV was analysed by a linear nausea/vomiting score, incidence of nausea and vomiting, and the need for antiemetic rescue. Our results showed a similar incidence of nausea and vomiting in all groups (G1 33%, G2 40%, G3 43%). However, when comparisons were made according to the time of assessment, combination therapy resulted in significantly lower PONV than droperidol in the first hour (0% vs. 13%, P < 0.05) and second hour (0% vs. 13%, P < 0.05), and than ondansetron on the first hour (0% vs. 13%, P < 0.05). A trend persisted up to the fourth hour but was not statistically significant in either group. In conclusion, droperidol and ondansetron are effective agents in the prevention of PONV, and their combination seems to provide slightly better results than either drug alone.